Zacks Investment Research
02 Nov 2026, 15:55 UTC · 59m ago
Wall Street Analysts Believe Replimune Group (REPL) Could Rally 26.8%: Here's is How to Trade
Impact · against what's priced in
The article provides no new fundamental catalysts for Replimune Group; it merely aggregates existing analyst sentiment and price targets. Because the market is already weighing the bullish case for RP1 against regulatory risks, these consensus targets do not shift the stock's current valuation assumptions.
- REPL+0.00
Already priced in
- The price assumes
the bulls value at up to 54% above the current price





